Shared by James Harvey
(ISSUP staff) - Seg, 01/07/2024 - 10:28
Format
Report
Published by / Citation
UNODC
A global reference on drug markets, trends and policy developments, the World Drug Report offers a wealth of data and analysis and in 2024 comprises several elements tailored to different audiences.
Shared by Rasha Abi Hana
- Sex, 09/02/2024 - 08:19
Format
Report
Published by / Citation
CCSA
The Cannabis, Mental Health, and Substance Use Health: Research Knowledge Exchange Event Summary Report presents the findings and themes discussed at an event jointly hosted by CCSA (Canadian Centre on Substance Use and Addiction) and the Mental Health Commission of Canada. With funding from Health Canada, the two organizations supported approximately 70 research teams in exploring the potential benefits, harms, and risks of cannabis on substance use health and mental health. The event provided a platform for these research teams to share their project results, observations, and experiences...
Shared by Rasha Abi Hana
- Sáb, 16/12/2023 - 14:09
Format
Report
SAMHSA report discusses the evidence supporting the effectiveness of screening, brief intervention, and referral to treatment (SBIRT) as a comprehensive approach, as well as for the implementation and effectiveness of the individual components of SBIRT for different behavioural health conditions.
The report describes briefly the underlying research that has been conducted in the prevention and early intervention of risky alcohol, substance abuse and tobacco consumption, as well as commonly reported mental health problems, and describes existing studies/models for specific populations and...
Shared by Rasha Abi Hana
- Sáb, 16/12/2023 - 13:55
Format
Toolkit
Published by / Citation
WHO
The ASSIST package, which consists of a brief questionnaire, a guide for health professionals on how to use the questionnaire in detecting and responding to substance use and also a self-help manual for cutting down or stopping substance use, is the result of more than 10-years work by WHO and an international group of researchers in the framework of the WHO ASSIST project. It is WHO’s response to the growing demand for guidance on how to best manage problems of substance use in non specialist health care settings. This approach, quick and easy to learn, useful for all substances including...
Shared by Rasha Abi Hana
- Qua, 08/11/2023 - 11:20
Format
News
Published by / Citation
NIDA
Call for Research Poster Abstract Submissions and Travel Award Requests
Submission Deadline: January 14, 2024
Present your international drug use and addiction research during the 2024 NIDA International Forum, which will be held June 14–17, 2024, in Montreal, Canada.
The NIDA International Program invites research poster abstract submissions and travel award applications from researchers around the world. Join for the Forum research symposium, interactive workshops, the poster session, and networking activities.
Shared by Rasha Abi Hana
- Qua, 06/09/2023 - 09:33
Format
Toolkit
Published by / Citation
CCSA
Pesquisas recentes revelaram um aumento nas hospitalizações infantis resultantes de envenenamento acidental por cannabis em várias regiões do Canadá. As crianças acham os comestíveis de cannabis atraentes devido à sua semelhança com guloseimas comuns, como doces, chocolates ou produtos de panificação. Os incidentes de intoxicação por cannabis ocorrem predominantemente dentro dos domicílios. É imperativo salientar os potenciais danos que os produtos à base de cannabis podem causar às crianças e a necessidade de um armazenamento seguro.
Esta publicação responde a algumas das perguntas mais frequentes levantadas nas discussões sobre a legislação sobre a cannabis. Embora o foco principal seja o uso de cannabis para fins recreativos, a legislação relevante para outros usos, incluindo produtos derivados da cannabis medicinal e comercial, como cosméticos, produtos de bem-estar e alimentos, está incluída, a fim de fornecer o contexto necessário para várias iniciativas políticas.
The event is jointly organized by the United Nations Office on Drug and Crime (UNODC) Civil Society Unit and the Vienna NGO Committee on Drugs (VNGOC).
Ms Chloe Carpientier (Chief, UNODC Drugs Research Section) will present the main...
De todas as substâncias ilícitas, a cannabis se destaca como a mais cultivada, traficada e abusada do gênero. Tem efeitos significativos no corpo e na mente humana, alterando as percepções sensoriais, o humor, as habilidades cognitivas, a coordenação motora e o senso de si e do tempo. Nesta lista de leitura, você pode descobrir mais sobre cannabis e uso de cannabis. Você também pode visitar a rede ISSUP dedicada ao tema para mais materiais e recursos de leitura.
1) A fundação para o álcool e a droga elaborou uma ficha informativa sobre a cannabis, que fornece uma definição, informações...
Hasin, D., & Walsh, C. (2020). Cannabis use, cannabis use disorder, and comorbid psychiatric illness: a narrative review. Journal of Clinical Medicine, 10(1), 15.
Abstract
As attitudes toward cannabis, its legal status, and patterns of use continue to evolve, the landscape surrounding this substance is in a constant state of flux. Against this backdrop, this review aims to provide an up-to-date overview of the literature on the comorbidity of cannabis use and cannabis use disorder (CUD) with other substance use and psychiatric disorders.
Results:
A strong body of literature shows associations between cannabis use and CUD with other drug use, psychosis, mood disorders, anxiety disorders, and personality disorders.
Belete, H., Mekonen, T., Espinosa, D. C., Ambaw, F., Connor, J., Chan, G., ... & Leung, J. (2023). Cannabis use in Sub‐Saharan Africa: a systematic review and meta‐analysis. Addiction.
Abstrair
Antecedentes e Objetivos
Os dados mais disponíveis sobre a prevalência do consumo de cannabis provêm de inquéritos populacionais realizados em países de elevado rendimento na América do Norte, Oceânia e Europa. Sabe-se menos sobre a prevalência do consumo de cannabis em África. Esta revisão sistemática teve como objetivo resumir o consumo de cannabis na população em geral na África Subsaariana desde 2010.
Resultados
O estudo incluiu 53 estudos e incluiu 13.239 participantes.
Entre os adolescentes, a prevalência de uso de maconha ao longo da vida, 12 meses e 6 meses foi...
Shared by Rasha Abi Hana
- Qui, 22/12/2022 - 08:40
Format
Scientific article
Published by / Citation
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022).
Introdução
Há crescente interesse e evidências para o uso de medicamentos canabinoides no tratamento do transtorno por uso de cannabis, mas pouco exame dos correlatos do tratamento bem-sucedido. Este artigo é uma análise secundária de um ensaio clínico randomizado controlado por placebo de nabiximols para o tratamento do transtorno do uso de cannabis (CUD), com o objetivo de identificar quais características do cliente e do tratamento afetam o engajamento e os resultados do tratamento.
Método
Modelos de regressão múltipla bayesiana foram usados para examinar o impacto da idade, sexo...
Shared by Rasha Abi Hana
- Qui, 17/11/2022 - 13:27
Format
Scientific article
Published by / Citation
Mills, L., Dunlop, A., Montebello, M. et al. Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder. Subst Abuse Treat Prev Policy 17, 67 (2022). https://doi.org/10.1186/s13011-022-00493-z
Introduction and aims
There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of a randomised placebo-controlled trial of nabiximols for the treatment of cannabis use disorder (CUD), aiming to identify which client and treatment characteristics impact treatment engagement and outcomes.
Method
Bayesian multiple regression models were used to examine the impact of age, gender, duration of regular cannabis use, daily...
O ISSUP Chile apresentou um webinar sobre os resultados da pesquisa atual sobre o impacto do uso de cannabis no cérebro adolescente em desenvolvimento.
O webinar aconteceu nesta quinta-feira, 10 de novembro de 2022, às 17h30. (horário...
Shared by Rasha Abi Hana
- Seg, 28/02/2022 - 11:03
Format
Scientific article
Published by / Citation
Imtiaz, S., Wells, S., Rehm, J. et al. Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020. Subst Abuse Treat Prev Policy 17, 14 (2022). https://doi.org/10.1186/s13011-022-00441-x
The novel coronavirus disease (COVID-19) pandemic has resulted in substantial burden of disease in Canada. Daily cannabis use is most strongly implicated in the cannabis-attributable burden of disease. In the context of the novel coronavirus disease (COVID-19) pandemic in Canada, the trends were characterised in daily cannabis use in the overall sample and various population subgroups, and examined risk characteristics associated with daily cannabis use.
The specific objectives of this study were as follows:
Characterise trends in daily cannabis use in the overall sample and various...